Recombinant quadrivalent enterovirus vaccine (Saccharomyces hansonensis)

重组四价肠道病毒疫苗（汉逊酵母）

Report date: 2026/04/30 20:00:20

Base Information

Drug NameRecombinant quadrivalent enterovirus vaccine (Saccharomyces hansonensis)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsEnterovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesWeier Taike (Beijing) Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWeier Taike (Beijing) Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsEnterovirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A